{"id":"NCT04537923","sponsor":"Eli Lilly and Company","briefTitle":"A Study of Tirzepatide (LY3298176) Versus Insulin Lispro (U100) in Participants With Type 2 Diabetes Inadequately Controlled on Insulin Glargine (U100) With or Without Metformin","officialTitle":"A Randomized, Phase 3, Open-label Trial Comparing the Effect of the Addition of Tirzepatide Once Weekly Versus Insulin Lispro (U100) Three Times Daily in Participants With Type 2 Diabetes Inadequately Controlled on Insulin Glargine (U100) With or Without Metformin (SURPASS-6)","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2020-10-19","primaryCompletion":"2022-10-11","completion":"2022-11-01","firstPosted":"2020-09-03","resultsPosted":"2023-11-02","lastUpdate":"2023-11-02"},"enrollment":1428,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Type 2 Diabetes"],"interventions":[{"type":"DRUG","name":"Tirzepatide","otherNames":["LY3298176"]},{"type":"DRUG","name":"Insulin Lispro (U100)","otherNames":["LY275585"]}],"arms":[{"label":"5 mg Tirzepatide","type":"EXPERIMENTAL"},{"label":"10 mg Tirzepatide","type":"EXPERIMENTAL"},{"label":"15 mg Tirzepatide","type":"EXPERIMENTAL"},{"label":"Insulin Lispro","type":"ACTIVE_COMPARATOR"}],"summary":"The purpose of this study is to compare the safety and efficacy of the study drug tirzepatide to insulin lispro (U100) three times a day in participants with type 2 diabetes that are already on insulin glargine (U100), with or without metformin.","primaryOutcome":{"measure":"Change From Baseline in Hemoglobin A1c (HbA1c) (Pooled Doses of Tirzepatide 5 mg, 10 mg and 15 mg)","timeFrame":"Baseline, Week 52","effectByArm":[{"arm":"Pooled 5 mg/10 mg/15 mg Tirzepatide","deltaMin":-2.26,"sd":0.048},{"arm":"Insulin Lispro","deltaMin":-1.16,"sd":0.049}],"pValues":[{"comp":"OG000 vs OG001","p":"<0.001"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":5,"exclusionCount":8},"locations":{"siteCount":135,"countries":["United States","Argentina","Belgium","Brazil","Czechia","Germany","Greece","Hungary","Italy","Mexico","Puerto Rico","Romania","Russia","Slovakia","Spain","Turkey (TÃ¼rkiye)"]},"refs":{"pmids":["37786396"],"seeAlso":["https://trials.lillytrialguide.com/en-US/trial/11LK1nZPXq4bEVBd2Mdi2i"]},"adverseEventsSummary":{"seriousAny":{"events":20,"n":243},"commonTop":["Nausea","Covid-19","Diarrhoea","Decreased appetite","Dyspepsia"]}}